| Intermittent claudication: an overview AV Meru, S Mittra, B Thyagarajan, A Chugh Atherosclerosis 187 (2), 221-237, 2006 | 173 | 2006 |
| Effect of N-acetylcysteine and L-NAME on aluminium phosphide induced cardiovascular toxicity in rats. A Azad, SB Lall, S Mittra Acta pharmacologica Sinica 22 (4), 298-304, 2001 | 81 | 2001 |
| From a glucocentric to a lipocentric approach towards metabolic syndrome S Mittra, VS Bansal, PK Bhatnagar Drug Discovery Today 13 (5-6), 211-218, 2008 | 70 | 2008 |
| Cholinesterase inhibition by aluminium phosphide poisoning in rats and effects of atropine and pralidoxime chloride. S Mittra, SS Peshin, SB Lall Acta Pharmacologica Sinica 22 (1), 37-39, 2001 | 65 | 2001 |
| 5-Hydroxytryptamine-inhibiting property of Feverfew: role of parthenolide content. S Mittra, A Datta, SK Singh, A Singh Acta Pharmacologica Sinica 21 (12), 1106-1114, 2000 | 54 | 2000 |
| An experimental study on cardiotoxicity of aluminium phosphide. SB Lall, K Sinha, S Mittra, SD Seth Indian journal of experimental biology 35 (10), 1060-1064, 1997 | 51 | 1997 |
| Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta S Mittra, M Singh Molecular and cellular biochemistry 183, 63-67, 1998 | 47 | 1998 |
| Antihyperglycemic effect of Annona squamosa hexane extract in type 2 diabetes animal model: PTP1B inhibition, a possible mechanism of action? JA Davis, S Sharma, S Mittra, S Sujatha, A Kanaujia, G Shukla, C Katiyar, ... Indian Journal of Pharmacology 44 (3), 326-332, 2012 | 41 | 2012 |
| Nature of action of Sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals JA Davis, S Singh, S Sethi, S Roy, S Mittra, G Rayasam, V Bansal, ... Indian journal of pharmacology 42 (4), 229-233, 2010 | 40 | 2010 |
| Gs and Gi coupling of adrenomedullin in adult rat ventricular myocytes S Mittra, JP Bourreau American Journal of Physiology-Heart and Circulatory Physiology 290 (5 …, 2006 | 40 | 2006 |
| Increase in weight induced by muraglitazar, a dual PPARα/γ agonist, in db/db mice: adipogenesis/or oedema? S Mittra, G Sangle, R Tandon, S Sharma, S Roy, V Khanna, A Gupta, ... British journal of pharmacology 150 (4), 480-487, 2007 | 37 | 2007 |
| Role of cyclooxygenase in ventricular effects of adrenomedullin: is adrenomedullin a double-edged sword in sepsis? S Mittra, JM Hyvelin, Q Shan, F Tang, JP Bourreau American Journal of Physiology-Heart and Circulatory Physiology 286 (3 …, 2004 | 37 | 2004 |
| Role of peripheral 5-HT1A receptors in detrusor over activity associated with partial bladder outlet obstruction in female rats S Mittra, S Malhotra, KS Naruganahalli, A Chugh European journal of pharmacology 561 (1-3), 189-193, 2007 | 28 | 2007 |
| Topiramate and type 2 diabetes: an old wine in a new bottle V Khanna, S Arumugam, S Roy, S Mittra, VS Bansal Expert Opinion on Therapeutic Targets 12 (1), 81-90, 2008 | 22 | 2008 |
| Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: preclinical efficacy and safety in db/db mice S Roy, V Khanna, S Mittra, A Dhar, S Singh, DC Mahajan, P Priyadarsiny, ... Life sciences 81 (1), 72-79, 2007 | 21 | 2007 |
| RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes. S Singh, S Roy, S Sethi, B Benjamin, S Sundaram, V Khanna, ... European Journal of Pharmacology, 2011 | 20 | 2011 |
| Biosimilars and interchangeable biosimilars: facts every prescriber, payor, and patient should know. Insulins perspective SR Joshi, S Mittra, P Raj, VR Suvarna, SN Athalye Expert Opinion on Biological Therapy, 2022 | 9 | 2022 |
| Biological evaluation of RBx-0128, a potent and selective dipeptidyl peptidase-IV inhibitor in type 2 diabetes genetic model JA Davis, PS Kumar, S Singh, A Surender, S Roy, V Khanna, S Sethi, ... Indian Journal of Pharmacology 44 (6), 759-764, 2012 | 3 | 2012 |
| Effect of change in oxygen tension on release pattern and nature of endothelium-derived substances in isolated rabbit aorta. S Mittra, M Singh Acta Pharmacologica Sinica 22 (3), 215-224, 2001 | 2 | 2001 |
| Comparative clinical efficacy and safety of insulin glargine 300 U/ml (Toujeo) versus insulin glargine 100 U/ml in type 2 diabetes and type 1 diabetes: A systematic literature … SR Joshi, G Singh, A Marwah, S Mittra, VR Suvarna, SN Athalye Diabetes, Obesity and Metabolism 25 (6), 1589-1606, 2023 | 1 | 2023 |
